This extensive portfolio includes the following products:
These cells are basically differentiated, adherent and predominantly derived from tissue. In culture, they retain most of the special structures and functions such as in vivo cells. Cells from Clonetics are subject to strict quality criteria. Thus, all cells are HIV-1, hepatitis B and C negative and free from mycoplasma contamination. Available either "cryopreserved", in cell culture flasks or trays, or as pellets in RNAlater®.
The Poetics™ stem cell, progenitor cell and media product line includes a collection of human and animal cells derived from hematopoietic, body fat and neuronal systems. Human immune cells are taken either from the peripheral blood or the umbilical cord. The purity of the removed cells is checked by flow cytometry.
AllCells is an industry leader in the procurement of human hematological tissues. In February 2019, Lonza and AllCells entered into a collaboration to manufacture and globally commercialize a broad range of hematopoietic primary cells. This partnership extends Lonza's range of hematopoietic cells and now allows users to choose from a very wide range of high-quality primary cells. AllCells is known for its high-quality cells and flexibility to adapt to unique customer requirements. Comprehensive documentation is provided to comply with FDA and EU regulations for the collection of tissues and cells for human use. The donors will be examined in accordance with GMP, FDA, CFR 21CFR1271 and EU Directives 2004/23 / EC and 2006/17 / EC.s.
The new CellBio service from Lonza offers optimal individual cell support for your research. This includes cell isolation from tissues, characterization of cells, modification of existing catalog products, services such as cell banking and cell expansion, and immortalization of cells.